RxSight's market cap is currently $1.22B. The company's EPS TTM is $-0.819; its P/E ratio is ―; RxSight is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 89.08M	$ 49.01M	$ 22.59M	$ 14.68M	$ 2.24M
Gross Profit	$ 53.77M	$ 21.33M	$ 4.52M	$ 1.71M	$ -1.82M
Operating Income	$ -50.09M	$ -63.32M	$ -52.79M	$ -35.41M	$ -46.07M
EBITDA	$ -41.04M	$ -57.78M	$ -41.01M	$ 32.15M	$ 130.20M
Net Income	$ -48.61M	$ -66.76M	$ -48.69M	$ 27.57M	$ 126.22M
Balance Sheet
Cash & Short-Term Investments	$ 127.18M	$ 105.80M	$ 159.33M	$ 68.97M	$ 80.67M
Total Assets	$ 182.55M	$ 150.16M	$ 192.72M	$ 100.68M	$ 110.43M
Total Debt	$ 3.01M	$ 44.99M	$ 44.93M	$ 30.75M	$ 5.52M
Net Debt	$ -6.68M	$ 33.16M	$ 20.57M	$ 16.76M	$ -2.44M
Total Liabilities	$ 22.19M	$ 60.26M	$ 54.48M	$ 398.21M	$ 415.04M
Stockholders' Equity	$ 160.36M	$ 89.90M	$ 138.24M	$ -297.53M	$ -304.61M
Cash Flow
Free Cash Flow	$ -46.41M	$ -61.24M	$ -46.65M	$ -37.74M	$ -44.70M
Operating Cash Flow	$ -41.59M	$ -58.85M	$ -44.71M	$ -35.20M	$ -40.62M
Investing Cash Flow	$ -22.13M	$ 39.95M	$ -81.91M	$ 15.59M	$ -5.87M
Financing Cash Flow	$ 61.52M	$ 6.33M	$ 137.34M	$ 25.24M	$ 1.33M

Currency in USD

RxSight Earnings and Revenue History

Income Statement >

RxSight Debt to Assets

Balance Sheet >

RxSight Cash Flow

Cash Flow >

RxSight Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing